GlassScriptPhysician profile
Justin T Saunders
NPI 1861602781
$26,162.22
in general payments reported to CMS, 2019-2025
40 companies · $1,315 in 2025
The $1,315 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,458 · 2020: $1,929 · 2021: $7,487 · 2022: $2,595 · 2023: $5,155 · 2024: $2,223 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,988 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Travel and Lodging: $1,418 · Consulting Fee: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,987.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Travel and Lodging | $1,417.94 |
| Consulting Fee | $887.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,538.75 | 2019-2025 | Aveir, Advisor, Ensite |
| Boston Scientific Corporation | $2,843.20 | 2019-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Medtronic, INC. | $2,650.17 | 2022-2024 | Na, Venaseal, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $2,299.56 | 2019 | |
| Atricure, INC. | $1,248.70 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cvrx, INC. | $831.65 | 2019-2025 | Barostim Neo System |
| Bard Peripheral Vascular, INC. | $724.04 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $553.86 | 2021-2023 | Optimizer |
| Merck Sharp & Dohme LLC | $421.98 | 2021-2025 | Verquvo, Steglujan, Steglatro |
| Acutus Medical, INC. | $312.44 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $300.62 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $273.67 | 2019-2025 | |
| Amgen INC. | $245.96 | 2019-2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $245.17 | 2019-2024 | |
| Heartflow, INC. | $237.43 | 2022-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.